Adult and Pediatric Vaccines Market Report

Global Adult and Pediatric Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：206
  • REPORT CODE：GMM858554
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

    Adult and Pediatric Vaccines market report explains the definition, types, applications, major countries, and major players of the Adult and Pediatric Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Merck & Co, Inc (US)

    • Emergent BioSolutions, Inc (US)

    • Sanofi Pasteur (France)

    • Daiichi Sankyo Company, Limited (Japan)

    • AstraZeneca (UK)

    • Mitsubishi Tanabe Pharma Corporation (Japan),

    • Bavarian Nordic (Denmark)

    • Pfizer, Inc (US)

    • Serum Institute of India Pvt Ltd (India)

    • CSL Limited (Australia)

    • GlaxoSmithKline plc (UK)

    • Johnson & Johnson (US)

    By Type:

    • Adult Vaccines

    • Pediatric Vaccines

    By End-User:

    • Hospitals

    • Medical Care Centers

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Adult and Pediatric Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Adult and Pediatric Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Adult and Pediatric Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Adult and Pediatric Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Adult and Pediatric Vaccines Market- Recent Developments

    • 6.1 Adult and Pediatric Vaccines Market News and Developments

    • 6.2 Adult and Pediatric Vaccines Market Deals Landscape

    7 Adult and Pediatric Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Adult and Pediatric Vaccines Key Raw Materials

    • 7.2 Adult and Pediatric Vaccines Price Trend of Key Raw Materials

    • 7.3 Adult and Pediatric Vaccines Key Suppliers of Raw Materials

    • 7.4 Adult and Pediatric Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Adult and Pediatric Vaccines Cost Structure Analysis

      • 7.5.1 Adult and Pediatric Vaccines Raw Materials Analysis

      • 7.5.2 Adult and Pediatric Vaccines Labor Cost Analysis

      • 7.5.3 Adult and Pediatric Vaccines Manufacturing Expenses Analysis

    8 Global Adult and Pediatric Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Adult and Pediatric Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Adult and Pediatric Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Adult and Pediatric Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Adult and Pediatric Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Adult Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adult and Pediatric Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Care Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Adult and Pediatric Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.2 UK Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.5 France Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.3 India Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Adult and Pediatric Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Adult and Pediatric Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Adult and Pediatric Vaccines Consumption (2017-2022)

    11 Global Adult and Pediatric Vaccines Competitive Analysis

    • 11.1 Merck & Co, Inc (US)

      • 11.1.1 Merck & Co, Inc (US) Company Details

      • 11.1.2 Merck & Co, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Merck & Co, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.1.4 Merck & Co, Inc (US) Adult and Pediatric Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Emergent BioSolutions, Inc (US)

      • 11.2.1 Emergent BioSolutions, Inc (US) Company Details

      • 11.2.2 Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.2.4 Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Sanofi Pasteur (France)

      • 11.3.1 Sanofi Pasteur (France) Company Details

      • 11.3.2 Sanofi Pasteur (France) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Sanofi Pasteur (France) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.3.4 Sanofi Pasteur (France) Adult and Pediatric Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Daiichi Sankyo Company, Limited (Japan)

      • 11.4.1 Daiichi Sankyo Company, Limited (Japan) Company Details

      • 11.4.2 Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.4.4 Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AstraZeneca (UK)

      • 11.5.1 AstraZeneca (UK) Company Details

      • 11.5.2 AstraZeneca (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AstraZeneca (UK) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.5.4 AstraZeneca (UK) Adult and Pediatric Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Mitsubishi Tanabe Pharma Corporation (Japan),

      • 11.6.1 Mitsubishi Tanabe Pharma Corporation (Japan), Company Details

      • 11.6.2 Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.6.4 Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bavarian Nordic (Denmark)

      • 11.7.1 Bavarian Nordic (Denmark) Company Details

      • 11.7.2 Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.7.4 Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer, Inc (US)

      • 11.8.1 Pfizer, Inc (US) Company Details

      • 11.8.2 Pfizer, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.8.4 Pfizer, Inc (US) Adult and Pediatric Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Serum Institute of India Pvt Ltd (India)

      • 11.9.1 Serum Institute of India Pvt Ltd (India) Company Details

      • 11.9.2 Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.9.4 Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 CSL Limited (Australia)

      • 11.10.1 CSL Limited (Australia) Company Details

      • 11.10.2 CSL Limited (Australia) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 CSL Limited (Australia) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.10.4 CSL Limited (Australia) Adult and Pediatric Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 GlaxoSmithKline plc (UK)

      • 11.11.1 GlaxoSmithKline plc (UK) Company Details

      • 11.11.2 GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.11.4 GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Johnson & Johnson (US)

      • 11.12.1 Johnson & Johnson (US) Company Details

      • 11.12.2 Johnson & Johnson (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Johnson & Johnson (US) Adult and Pediatric Vaccines Main Business and Markets Served

      • 11.12.4 Johnson & Johnson (US) Adult and Pediatric Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Adult and Pediatric Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Adult and Pediatric Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Adult and Pediatric Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Adult and Pediatric Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Adult and Pediatric Vaccines

    • Figure of Adult and Pediatric Vaccines Picture

    • Table Global Adult and Pediatric Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Adult and Pediatric Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Table North America Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure United States Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure Germany Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure China Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure Australia Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table Merck & Co, Inc (US) Company Details

    • Table Merck & Co, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Merck & Co, Inc (US) Adult and Pediatric Vaccines Product Portfolio

    • Table Emergent BioSolutions, Inc (US) Company Details

    • Table Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Product Portfolio

    • Table Sanofi Pasteur (France) Company Details

    • Table Sanofi Pasteur (France) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur (France) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Sanofi Pasteur (France) Adult and Pediatric Vaccines Product Portfolio

    • Table Daiichi Sankyo Company, Limited (Japan) Company Details

    • Table Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Product Portfolio

    • Table AstraZeneca (UK) Company Details

    • Table AstraZeneca (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (UK) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table AstraZeneca (UK) Adult and Pediatric Vaccines Product Portfolio

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Company Details

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Product Portfolio

    • Table Bavarian Nordic (Denmark) Company Details

    • Table Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Product Portfolio

    • Table Pfizer, Inc (US) Company Details

    • Table Pfizer, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc (US) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Pfizer, Inc (US) Adult and Pediatric Vaccines Product Portfolio

    • Table Serum Institute of India Pvt Ltd (India) Company Details

    • Table Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Product Portfolio

    • Table CSL Limited (Australia) Company Details

    • Table CSL Limited (Australia) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited (Australia) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table CSL Limited (Australia) Adult and Pediatric Vaccines Product Portfolio

    • Table GlaxoSmithKline plc (UK) Company Details

    • Table GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Product Portfolio

    • Table Johnson & Johnson (US) Company Details

    • Table Johnson & Johnson (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) Adult and Pediatric Vaccines Main Business and Markets Served

    • Table Johnson & Johnson (US) Adult and Pediatric Vaccines Product Portfolio

    • Figure Global Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US